OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(2)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
pride
(1)
Tissue
Cell culture
(1)
Epithelial cell
(1)
Disease
Colon cancer
(1)
Technology Type
Gel-based experiment
(1)
Mass Spectrometry
(1)
Publication Date
2023
(1)
Release Date
2024
(1)
2021
(1)
Lab affiliation
1 Center for Applied Medical Research, University of Navarra, Pio XII 55 Ave, 31008, Pamplona, Spain. 2 Institute of Health Research of Navarra (IdiSNA), Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Mass spectrometry and phosphorylation analysis of ORC1 protein, wild type or RNA-binding mutant (R441A, R444A and R465A), in GAA-RNA (RNA interactors of ORC1 identified by RIP-seq and iCLIP) knockdown or control conditions.
Mass spectrometry of wild type or mutant (RNA-binding) ORC1. Experiments were done in cellstransfected with a control ASO or an anti-GAA ASO, to knockdown RNA interactors of ORC1.
ORGANISM(S):
Homo sapiens (Human)
2023-10-24
|
PXD043232
|
Pride
Phosphoproteomics of orc1 with altered protein rna-binding
Cite
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
Not available
S-EPMC7995808
|
biostudies-literature
Cite
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets